Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This botanical combination pairs safflower oil (*Carthamus tinctorius*), a rich source of linoleic acid, with black ginger extract (*Kaempferia parviflora*), which is standardized for polymethoxyflavones such as 5,7-dimethoxyflavone. The primary mechanism of action involves the activation of **Sirtuin 1 (SIRT1)** and **AMP-activated protein kinase (AMPK)**, which are critical regulators of cellular energy metabolism, mitochondrial biogenesis, and glucose homeostasis. Additionally, the black ginger component exhibits inhibitory activity against **phosphodiesterase 5 (PDE5)**. This combination is primarily developed and marketed as a dietary supplement or functional food ingredient intended to support metabolic health, reduce visceral fat, and enhance physical endurance and energy expenditure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carthamus tinctorius seed oil + kaempferia parviflora rhizome extract.